Marshall Wace North America’s Integra LifeSciences IART Stock Holding History

Marshall Wace North America’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-16,587	Closed	-$741K	–	1293
2020 Q1	$741K	Buy	+16,587	New	+$870K	0.01%	677
2019 Q4	–	Sell	-171,645	Closed	-$10.3M	–	1424
2019 Q3	$10.3M	Buy	171,645 +117,372	+216%	+$6.99M	0.06%	258
2019 Q2	$3.03M	Sell	54,273 -4,124	-7%	-$212K	0.02%	465
2019 Q1	$3.25M	Buy	58,397 +12,683	+28%	+$646K	0.02%	396
2018 Q4	$2.06M	Buy	+45,714	New	+$2.51M	0.02%	420
2017 Q3	–	Sell	-280,867	Closed	-$15.4M	–	1379
2017 Q2	$15.4M	Buy	280,867 +223,333	+388%	+$10.7M	0.11%	229
2017 Q1	$2.42M	Buy	+57,534	New	+$2.46M	0.02%	548

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Marshall Wace North America's IART Position: Q2 2020 in Review

Marshall Wace North America sold out of Integra LifeSciences (IART) in Q2 2020, closing a stake of 16,587 shares — an estimated $741K sold.

Marshall Wace North America first reported a position in IART in Q1 2017 and held it in 7 quarters. The position peaked at $15.4M in Q2 2017. 264 funds tracked by Wall St. Rank hold IART as of Q2 2020.

Marshall Wace North America reported no remaining Integra LifeSciences position as of Q2 2020 after selling out during the quarter.
Marshall Wace North America sold 16,587 Integra LifeSciences shares in Q2 2020, an estimated $741K.
Marshall Wace North America first reported a position in Integra LifeSciences in Q1 2017 and held it in 7 quarters.
Marshall Wace North America's Integra LifeSciences position peaked at $15.4M in Q2 2017.
264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2020.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.